Your Ad Here

Evaluation

 


Browse: Links | Articles | Images | Videos  
Statistics
Pending Links: 0
Active Links: 90
Active Articles: 1
Active Videos: 0
Total Categories: 742
Sub Categories: 724

Like It? Tag It!
Blinklist  Delicious  Digg  Furl  Google  Magnolia

Reddit  Simpy  Spurl  StumbleUpon  Technorati  Yahoo

Popular Categories
Business and Economy
Computers and Internet
Travel Resources
Discussion Forums
Blogs and Bloggers
Arts and Humanities
Web Directories
Shopping Resources
Entertainment Resource
Health and Medical

Site of the Day
Online sweepstakes
Online sweepstakes

Dream & Win is the highest quality online lottery. Offering unique and luxuries prizes in the best odds to win. Luxury Cars, Amazing vacations and prestigious jewelry.

Links 2 Visit
Link Directory - Biz-King
Seo link directory organized by topics into categories.

Web Directory - Sleek
Seo web directory offering direct static links with affordable rates.

Web Directory - C2C-Tech
Web Link Directory offering quality websites and blogs.

Bidding Directory
Bid for Front the Page and Top 15 in this bidding Web directory.

Partners


SEO Friendly Certified
Directory Critic Button

Current Evaluation News Today

Branden Smith
Data provided by Scouts, Inc. Evaluation Smith is an electric athlete with the skills and outstanding play-speed to excel in all three phases of the game in college.

Wed, 07 Jan 2009 03:19:13 GMT

FDA Issues Complete Response Letter to Ipsen for Dysport Biologics License Application
Dec 29, 2008 - Regulatory News: Ipsen today announced that the US Food and Drug Administration issued a Complete Response Letter for its Biologics License Application for its Botulinum toxin Type A, Dysport.

Mon, 29 Dec 2008 18:34:10 GMT

Cytokinetics Retains Development and Commercialization Rights to Ispinesib and SB-743921
GlaxoSmithKline and Cytokinetics, Incorporated announced today that GSK has informed Cytokinetics that it will not exercise its option to license ispinesib or SB-743921 as provided under the Collaboration and ...

Wed, 24 Dec 2008 12:50:30 GMT

Napo Pharmaceuticals Announces Publication of Paper on Crofelemer for ...
SOUTH SAN FRANCISCO, Calif.-- --Dec 23, 2008 - Napo Pharmaceuticals, Inc ., announces that a paper entitled "Evaluation of Crofelemer in the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome Patients" ...

Tue, 23 Dec 2008 18:51:35 GMT

FDA Approves Gleevec to Prevent Recurrence of Rare Gastrointestinal Cancer
The U.S. Food and Drug Administration today approved Gleevec for a new indication a ' keeping cancer from growing in patients following surgical removal of a gastrointestinal stromal tumor or GIST.

Mon, 22 Dec 2008 11:58:36 GMT